why choose us

CME Courses

Showing 10 of 4,290 result(s)
Course: Relapsed/Refractory Multiple Myeloma: The Role of Community Hematologists/Oncologists in Advancing Care

Description: Significant advancements in multiple myeloma treatment have occurred in recent years, resulting in improved survival and quality o...

CME Credit: 1.00

Course: Linking Experts and Community Oncologists to Improve the Management of Gastric/GEJ Cancer in Rural and Underserved Communities – Lessons Learned

Description: While gastric and gastroesophageal junction (GEJ) cancers are relatively uncommon in the United States, the disease is not typical...

CME Credit: 1.00

Course: Reshaping the Role of CAR T-Cell Therapy for Community-Based Care of Non-Hodgkin Lymphoma

Description: Chimeric antigen receptor (CAR) T-cell therapies have transformed the treatment of non-Hodgkin lymphoma (NHL) that relapses after ...

CME Credit: 1.00

Course: An Evolving Landscape for Newly Diagnosed CLL: Individualizing Treatment Strategies in the Community

Description: Chronic lymphocytic leukemia (CLL) is a myeloproliferative disease characterized by the progressive accumulation of leukemic cells...

CME Credit: 1.00

Course: Advancing Equity in Relapsed/Refractory Multiple Myeloma: Integrating Emerging?CELMoD?Therapies Into Community Oncology Practice

Description: Multiple novel targets and agents are currently being evaluated for relapsed/refractory multiple myeloma (RRMM), including triple-...

CME Credit: 1.00

Course: Innovative Solutions for Expanding Access to Breast Cancer Care: A Focus on the PI3K/AKT/PTEN Pathway

Description: In recent years, the PI3K/AKT/PTEN pathway has emerged as an important player in breast cancer development. Up to 50% of patients ...

CME Credit: 1.00